Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Globe Newswire•16/10/2026•16:01 ET
0
Key Highlights
- ➤Prelude Therapeutics (PRLD) will participate in the Chardan Healthcare Conference on October 20, 2026.
- ➤Peggy Scherle and Bryant Lim will join a 2:00 p.m. ET fireside chat.
- ➤The fireside chat webcast recording will remain available for 90 days.
WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Chardan Healthcare Conference taking place in New York City on October 20, 2026.
On Tuesday, October 20, 2026, at 2:00 p.m. ET, Peggy Scherle, Ph.D., Chief Scientific Officer of Prelude and Bryant Lim, Chief Financial Officer, will participate in a fireside chat.
Get started
Create a free account to read the full story.